We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04478071
Recruitment Status : Completed
First Posted : July 20, 2020
Last Update Posted : February 17, 2023
Akebia Therapeutics Inc.
United States Department of Defense
Information provided by (Responsible Party):
Bentley J. Bobrow, The University of Texas Health Science Center, Houston

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 7, 2022
Actual Study Completion Date : March 7, 2022
Certification/Extension First Submitted : February 14, 2023